298 related articles for article (PubMed ID: 19776495)
1. Poly (ADP-Ribose) polymerase inhibition attenuates atherosclerotic plaque development in ApoE-/- mice with hyperhomocysteinemia.
Xie JJ; Yu X; Liao YH; Chen J; Yao R; Chen Y; Liao MY; Ding YJ; Tang TT; Cheng X
J Atheroscler Thromb; 2009 Oct; 16(5):641-53. PubMed ID: 19776495
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability.
Hans CP; Zerfaoui M; Naura AS; Catling A; Boulares AH
Cardiovasc Res; 2008 Jun; 78(3):429-39. PubMed ID: 18245064
[TBL] [Abstract][Full Text] [Related]
4. Poly (ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by hyperhomocysteinemia in rats.
Yu X; Cheng X; Xie JJ; Liao MY; Yao R; Chen Y; Ding YJ; Tang TT; Liao YH
Cardiovasc Drugs Ther; 2009 Apr; 23(2):121-7. PubMed ID: 18949543
[TBL] [Abstract][Full Text] [Related]
5. PARP1 is required for adhesion molecule expression in atherogenesis.
von Lukowicz T; Hassa PO; Lohmann C; Borén J; Braunersreuther V; Mach F; Odermatt B; Gersbach M; Camici GG; Stähli BE; Tanner FC; Hottiger MO; Lüscher TF; Matter CM
Cardiovasc Res; 2008 Apr; 78(1):158-66. PubMed ID: 18093987
[TBL] [Abstract][Full Text] [Related]
6. Thieno[2,3-c]isoquinolin-5-one, a potent poly(ADP-ribose) polymerase inhibitor, promotes atherosclerotic plaque regression in high-fat diet-fed apolipoprotein E-deficient mice: effects on inflammatory markers and lipid content.
Hans CP; Zerfaoui M; Naura AS; Troxclair D; Strong JP; Matrougui K; Boulares AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):150-8. PubMed ID: 19124646
[TBL] [Abstract][Full Text] [Related]
7. Methionine-induced hyperhomocysteinemia modulates lipoprotein profile and oxidative stress but not progression of atherosclerosis in aged apolipoprotein E knockout mice.
Song Y; Cho M; Cho C; Rosenfeld ME
J Med Food; 2009 Feb; 12(1):137-44. PubMed ID: 19298207
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of mild hyperhomocysteinemia during the development of atherosclerosis in apolipoprotein E-deficient and normal mice.
Aléssio AC; Santos CX; Debbas V; Oliveira LC; Haddad R; Annichino-Bizzacchi JM
Exp Mol Pathol; 2011 Feb; 90(1):45-50. PubMed ID: 20696152
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
11. Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice.
Zhou J; Werstuck GH; Lhoták S; de Koning AB; Sood SK; Hossain GS; Møller J; Ritskes-Hoitinga M; Falk E; Dayal S; Lentz SR; Austin RC
Circulation; 2004 Jul; 110(2):207-13. PubMed ID: 15210586
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation.
Qin WD; Wei SJ; Wang XP; Wang J; Wang WK; Liu F; Gong L; Yan F; Zhang Y; Zhang M
Biochim Biophys Acta; 2013 Jan; 1833(1):59-68. PubMed ID: 23085506
[TBL] [Abstract][Full Text] [Related]
13. Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase.
Benkö R; Pacher P; Vaslin A; Kollai M; Szabó C
Life Sci; 2004 Jul; 75(10):1255-61. PubMed ID: 15219813
[TBL] [Abstract][Full Text] [Related]
14. MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis.
Yang L; Gao C
Yonsei Med J; 2019 Mar; 60(3):298-307. PubMed ID: 30799593
[TBL] [Abstract][Full Text] [Related]
15. Involvement of histone methylation in macrophage apoptosis and unstable plaque formation in methionine-induced hyperhomocysteinemic ApoE
Cong G; Yan R; Huang H; Wang K; Yan N; Jin P; Zhang N; Hou J; Chen D; Jia S
Life Sci; 2017 Mar; 173():135-144. PubMed ID: 28188730
[TBL] [Abstract][Full Text] [Related]
16. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice].
Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM
Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757
[TBL] [Abstract][Full Text] [Related]
17. Role of redox factor-1 in hyperhomocysteinemia-accelerated atherosclerosis.
Dai J; Li W; Chang L; Zhang Z; Tang C; Wang N; Zhu Y; Wang X
Free Radic Biol Med; 2006 Nov; 41(10):1566-77. PubMed ID: 17045925
[TBL] [Abstract][Full Text] [Related]
18. Role of PARP on iNOS pathway during endotoxin-induced acute lung injury.
Kiefmann R; Heckel K; Doerger M; Schenkat S; Kupatt C; Stoeckelhuber M; Wesierska-Gadek J; Goetz AE
Intensive Care Med; 2004 Jul; 30(7):1421-31. PubMed ID: 15197441
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase 1 deficiency increases nitric oxide production and attenuates aortic atherogenesis through downregulation of arginase II.
Wei SJ; Cheng L; Liang ES; Wang Q; Zhou SN; Xu H; Hui LH; Ge ZM; Zhang MX
Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):114-122. PubMed ID: 27757983
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
